In the National Lung Screening Trial, screening with 2 years of annual low-dose computed tomography (LDCT) achieved a 20% decrease in lung cancer mortality in high-risk populations when compared with […] Read more
During the 17th annual Quantitative Imaging Workshop held in late Fall 2020, the Initiative for Early Lung Cancer Research on Treatment (IELCART) offered two sessions with panel discussions exploring the […] Read more
In the United States, racial disparities in lung cancer incidence are known to exist. This is most likely caused by higher smoking prevalence among non-Hispanic Black adults compared to non-Hispanic […] Read more
Discussions about lung cancer screening in Poland started in 2006, and between 2008 and 2010 four lung cancer screening programs were independently implemented by thoracic surgeons in Szczecin, Gdańsk, Poznań, […] Read more
To address the issue of low-dose CT screening, during the COVID-19 pandemic, for lung cancer and management of both screen-detected nodules and incidentally detected nodules, various eminent organizations and expert […] Read more
Using LDCT to Boost Lung Cancer Prevention Strategies: A Pro/Con By Ugo Pastorino, MD Now we know from robust randomized trials that systematic screening with low-dose computed tomography (LDCT) of […] Read more
By Brendon Stiles, MD, and Drew Moghanaki, MD, MPH Posted: June 24, 2020 Annual low-dose computed tomography (LDCT) detects more early-stage lung cancers and saves lives by preventing death in […] Read more